|
⚲
|
| Keyboard |
| Louis Tartaglia | |
|---|---|
| Firm | Cure Ventures Management LP |
| Address | 349 Newbury Street 2nd Floor Boston, MA 02115 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cure Ventures Management LP | |||||
| Cure Ventures Fund II LP | 021-567406 | Executive Officer | 329.2 M | ||
| Cure Ventures Fund I LP | 021-400415 | Executive Officer | 350.5 M of 350.5 M |
360.8 M | |
| Entrada Therapeutics Inc | 021-328899 | Director | 34.0 M of 59.0 M |
||
| Cycloporters Inc | 021-274261 | Executive Officer | 0.6 M of 1.6 M |
||
| Solstice Biologics LLC | 021-225788 | Director | 7.5 M of 7.5 M |
||
| Ember Therapeutics Inc | 021-170448 | Executive Officer | 3.2 M of 34.2 M |
||
| Zafgen Inc | 021-162666 | Director | 6.1 M | ||
| Zafgen Inc | 021-94401 | Director | 8.1 M of 10.1 M |
||